Preliminary evidence was produced by inhibitors capable of blocking the interaction between immune cells and cancer cells like PD-1, expressed by T-cells, and PDL1 expressed by cancer cells with the aim of rescuing T-cells anti-tumor activity [80]. Here, PDCD1 is linked to cancer.